apoB level in cholesterol may predict CAD risk
apoB level in cholesterol may predict CAD risk
Blood levels of apolipoprotein B (apoB) in cholesterol may be a better predictor in determining a woman's risk for coronary artery disease (CAD) than blood levels of low-density lipoprotein (LDL), according to a report from University Hospital Utrecht in The Netherlands.1 apoB can be measured by blood tests that take about an hour using a kit like that from Exocell in Philadelphia. Exocell's kit contains 90 samples and costs $275, so each test costs approximately $3. Researchers have already established the superiority of apoB as a predictor in men, but few studies have focused on the protein in women. When only cholesterol levels and apoB levels were considered, apoB was superior to total cholesterol, LDL, high-density lipoprotein, and triglycerides in determining risk for CAD. Blood plasma apoB concentrations reflect the number of LDL, VLDL (very low-density lipoprotein), and triglyceride particles in the arteries. The five-year study involved 289 women undergoing their first coronary angiography.
Reference
1. Westerveld HT, van Lennep JER, van Lennep H, et al. Apolipoprotein B and coronary artery disease in women: A cross-sectional study in women undergoing their first coronary angiography. Arteriosclerosis, Thrombosis and Vascular Biology 1998;18:1101.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.